US raised 16-point proposals in Singapore meeting

The government disclosed 16-point proposals related to Korea's new drug pricing policy, which were demanded by the United States in the Singapore meeting, and the salient points of which are as follows:

1) Easier access of both newly-invested drugs and generic products to the reimbursement scheme;

2) No discrimination in the pricing screening of newly-invested drugs and generic products r...